Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K24 HL087713, U01 HL098964, R01 HL090335)
Received: 23 August 2018
Accepted: 22 February 2019
First Online: 11 March 2019
Ethics approval and consent to participate
: The Makerere University School of Medicine Research Ethics Committee, the Mulago Hospital Research and Ethics Committee, the Uganda National Council for Science and Technology, and the University of California San Francisco Committee on Human Research approved the protocol. Subjects provided written, informed consent.
: S.V.L. is the founder, consultant, and member of the Board of Directors of Siolta Therapeutics Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.